Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$405M |
| 2 |
Gilead Sciences
GILD
|
+$314M |
| 3 |
Union Pacific
UNP
|
+$229M |
| 4 |
Intel
INTC
|
+$224M |
| 5 |
Meta Platforms (Facebook)
META
|
+$207M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$342M |
| 2 |
SWY
SAFEWAY INC
SWY
|
+$210M |
| 3 |
TSMC
TSM
|
+$174M |
| 4 |
GSK
GSK
|
+$156M |
| 5 |
Johnson & Johnson
JNJ
|
+$149M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.05% |
| 2 | Technology | 11.94% |
| 3 | Consumer Discretionary | 11.2% |
| 4 | Industrials | 10.96% |
| 5 | Consumer Staples | 9.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PDLI
101
DELISTED
PDL BioPharma, Inc.
PDLI
| $84.2M | 0.18% |
11,971,554
+200,554
| +2% | +$1.45M |
|
102
Teva Pharmaceuticals
TEVA
$42.5B
| $83.4M | 0.18% |
1,338,963
+374,300
| +39% | +$21.8M |
|
|
MIC
103
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $83.4M | 0.18% |
1,012,900
-426,400
| -30% | -$32.4M |
|
|
BRCM
104
DELISTED
BROADCOM CORP CL-A
BRCM
| $83M | 0.18% |
1,917,657
+153,200
| +9% | +$6.68M |
|
105
TechnipFMC
FTI
$29.5B
| $81.8M | 0.17% |
2,970,778
+2,849,684
| +2,353% | +$83.5M |
|
106
Intercontinental Exchange
ICE
$84.9B
| $81.1M | 0.17% |
+1,738,990
| New | +$78.4M |
|
|
WNR
107
DELISTED
Western Refining Inc
WNR
| $80.9M | 0.17% |
1,637,100
+1,300,600
| +387% | +$54.3M |
|
|
GGP
108
DELISTED
GGP Inc.
GGP
| $80.8M | 0.17% |
2,732,700
+2,177,000
| +392% | +$65M |
|
109
Charter Communications
CHTR
$18.8B
| $79M | 0.17% |
408,900
+175,500
| +75% | +$30.4M |
|
|
ESRX
110
DELISTED
Express Scripts Holding Company
ESRX
| $78.8M | 0.17% |
908,139
+562,900
| +163% | +$47.2M |
|
|
BRFS
111
DELISTED
BRF SA
BRFS
| $77.8M | 0.17% |
3,932,960
+1,509,200
| +62% | +$33.5M |
|
|
LNKD
112
DELISTED
LinkedIn Corporation
LNKD
| $77M | 0.16% |
308,300
+15,000
| +5% | +$3.72M |
|
113
United Therapeutics
UTHR
$22.1B
| $77M | 0.16% |
446,500
+261,262
| +141% | +$39.8M |
|
114
Euronet Worldwide
EEFT
$2.64B
| $76.6M | 0.16% |
1,304,045
+205,800
| +19% | +$10.9M |
|
|
WOOF
115
DELISTED
VCA Inc.
WOOF
| $76.2M | 0.16% |
1,389,200
-190,900
| -12% | -$9.98M |
|
116
Regeneron Pharmaceuticals
REGN
$82.1B
| $75.6M | 0.16% |
+167,488
| New | +$71M |
|
|
MGLN
117
DELISTED
Magellan Health Services, Inc.
MGLN
| $73.7M | 0.16% |
1,040,244
-126,655
| -11% | -$7.97M |
|
118
Bank of America
BAC
$448B
| $73.6M | 0.16% |
4,782,866
-6,668,300
| -58% | -$107M |
|
119
Ecolab
ECL
$79.8B
| $73M | 0.16% |
638,322
+227,300
| +55% | +$24.9M |
|
120
Starbucks
SBUX
$122B
| $72.2M | 0.15% |
1,525,784
-1,023,908
| -40% | -$46M |
|
121
TFS Financial
TFSL
$4.83B
| $72.1M | 0.15% |
4,911,955
+157,542
| +3% | +$2.26M |
|
|
AZPN
122
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $72.1M | 0.15% |
1,872,600
-18,200
| -1% | -$701K |
|
|
ETP
123
DELISTED
Energy Transfer Partners L.p.
ETP
| $71.1M | 0.15% |
1,275,213
+1,227,249
| +2,559% | +$72.8M |
|
124
Verisk Analytics
VRSK
$23.6B
| $70.7M | 0.15% |
990,200
-219,366
| -18% | -$14.8M |
|
125
Sony
SONY
$139B
| $70.3M | 0.15% |
13,126,000
+8,908,000
| +211% | +$45M |
|
Similar funds
Jim Simons's Q1 2015 Portfolio in Review
As of Q1 2015, Jim Simons held 3,575 positions worth $47B, up 13% from $41.4B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
Jim Simons deployed $4.23B of net new capital in Q1 2015, opening 633 new positions and adding to 1,637 existing holdings. Its largest new stake was Amazon: 23,057,100 shares worth $429M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 12% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was McDonald's, an estimated $342M trimmed.
- Jim Simons's largest Q1 2015 buy was Amazon: 23,057,100 shares worth $429M.
- Jim Simons added most to Gilead Sciences in Q1 2015, an estimated $314M increase.
- Jim Simons's biggest Q1 2015 reduction was McDonald's, cutting an estimated $342M.
- Jim Simons fully exited SAFEWAY INC in Q1 2015, selling an estimated $210M.
- Jim Simons's ten largest holdings make up 9.9% of its $47B portfolio in Q1 2015.
- Jim Simons opened 633 new positions and closed 438 in Q1 2015.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $47B.
Based on Renaissance Technologies's 13F filing for Q1 2015, filed 13 May 2015.